Dupixent ® (dupilumab) Demonstrated Superiority Over Xolair ® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-

1. Homepage
2. Finance
3. Dupixent ® (dupilumab) Demonstrated Superiority Over Xolair ® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-